Disparities and Persistence in Systemic Hormone Therapy Among Menopausal Women: Insights from a Large Real-World Analysis
Highlight
• Only about one-fifth of women diagnosed with menopause initiated systemic hormone therapy (HT) within one year.
• Younger age, prior hysterectomy, and local hormone use increase likelihood of HT initiation.
• Black racial and Hispanic ethnic identities predict lower initiation rates and faster HT discontinuation.
• Median duration of first HT episode is 6.6 months, with less than 40% continuation at 12 months, highlighting persistence challenges.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.